MBST® Science & Research

Basic Research | In-vitro-studies

2025

Cellular effects of magnetic resonance

Thöni, A. Buchter, A. Flarer, J. Lampe, C. Schlegel & M. Egg., 2025: Understanding therapeutic nuclear magnetic resonance (tNMR): splitting of components indicates its unique efficacy, Poster presentation, BiOS, 2025, San Francisco, California, USA, in Proceedings Volume 13340, Quantum Effects and Measurement Techniques in Biology and Biophotonics II;133400E (2025)

 

Abstract

Therapeutic Nuclear Magnetic Resonance (tNMR, MBST®, Wetzlar, Germany) was derived from MRI, reducing the magnetic field intensity to 0.4mT and the radiofrequency to <18kHz, to induce water proton resonance conditions. However, it was unknown whether proton resonances were essential for the manifold cellular effects observed, such as changes in the circadian clock, the hypoxic signaling pathway and in reactive oxygen species (ROS). Therefore, chip cards were designed to selectively induce either tNMR, the sweep field (0.4mT, 50Hz) or the radiofrequency (up to 18kHz). Preliminary data now indicate distinct cellular responses for each of the three modes, regarding ROS partitioning, lactate metabolism, and cellular proliferation rates. Interestingly, tNMR affected cellular processes known to require proton gradients, such as mitochondrial respiration and lactate shuttling via proton-coupled Monocarboxylate Transporters. This suggests that tNMR potentially enhances cellular proton motive forces. Conclusively, our results highlight a huge potential for all three applications, tNMR, sweep field and radiofrequency, and emphasize the unique role of tNMR.

2025

Weak magnetic fields and ROS in cancer treatment

Egg & T. Kietzmann, 2025: Little strokes fell big oaks: The use of weak magnetic fields and reactive oxygen species to fight cancer, Redox Biology 79 (2025) 103483

Abstract

The increase in early-stage cancers, particularly gastrointestinal, breast and kidney cancers, has been linked to lifestyle changes such as consumption of processed foods and physical inactivity, which contribute to obesity and diabetes – major cancer risk factors. Conventional treatments such as chemotherapy and radiation often lead to severe long-term side effects, including secondary cancers and tissue damage, highlighting the need for new, safer and more effective therapies, especially for young patients. Weak electromagnetic fields (WEMF) offer a promising non-invasive approach to cancer treatment. While WEMF have been used therapeutically for musculoskeletal disorders for decades, their role in oncology is still emerging. WEMFs affect multiple cellular processes through mechanisms such as the radical pair mechanism (RPM), which alters reactive oxygen species (ROS) levels, mitochondrial function, and glycolysis, among others. This review explores the potential of WEMF in conjunction with reactive oxygen species as a cancer therapy, highlighting WEMFs selective targeting of cancer cells and its non-ionizing nature, which could reduce collateral damage compared to conventional treatments. In addition, synchronization of WEMF with circadian rhythms may further enhance its therapeutic efficacy, as has been demonstrated in other cancer therapies.

2024

Triggering clock-dependent effects in cellular
clocks and the central role of superoxide

Thoeni, E. Y. Dimova, T. Kietzmann, R. J. Usselman & M. Egg, 2024: Therapeutic nuclear magnetic resonance and intermittent hypoxia trigger time dependent on/off effects in circadian clocks and confirm a central role of superoxide in cellular magnetic field effects, Redox Biology, 06/2024, 72, 103152

Abstract

Cellular magnetic field effects are assumed to base on coherent singlet-triplet interconversion of radical pairs that are sensitive to applied radiofrequency (RF) and weak magnetic fields (WEMFs), known as radical pair mechanism (RPM). As a leading model, the RPM explains how quantum effects can influence biochemical and cellular signalling. Consequently, radical pairs generate reactive oxygen species (ROS) that link the RPM to redox processes, such as the response to hypoxia and the circadian clock. Therapeutic nuclear magnetic resonance (tNMR) occupies a unique position in the RPM paradigm because of the used frequencies, which are far below the range of 0.1–100 MHz postulated for the RPM to occur. Nonetheless, tNMR was shown to induce RPM like effects, such as increased extracellular H2O2 levels and altered cellular bioenergetics. In this study we compared the impact of tNMR and intermittent hypoxia on the circadian clock, as well as the role of superoxide in tNMR induced ROS partitioning. We show that both, tNMR and intermittent hypoxia, exert on/off effects on cellular clocks that are dependent on the time of application (day versus night). In addition, our data provide further evidence that superoxide plays a central role in magnetic signal transduction. tNMR used in combination with scavengers, such as Vitamin C, led to strong ROS product redistributions. This discovery might represent the first indication of radical triads in biological systems.

2024

Influence on Schwann cells and
promotion of neurite growth

Rad, L. Weigl, B. Steinecker-Frohnwieser, S. Stadlmayr, F. Millesi, M. Haertinger, A. Borger, P. Supper, L. Semmler, S. Wolf, A. Naghilou, T. Weiss, H. G. Kress & C. Radtke, 2024: Nuclear Magnetic Resonance Treatment Induces ßNGF Release from Schwann Cells and Enhances the Neurite Growth of Dorsal Root Ganglion Neurons In Vitro, Cells, 13, 1544.

Abstract

Peripheral nerve regeneration depends on close interaction between neurons and Schwann cells (SCs). After nerve injury, SCs produce growth factors and cytokines that are crucial for axon re-growth. Previous studies revealed the supernatant of SCs exposed to nuclear magnetic resonance therapy (NMRT) treatment to increase survival and neurite formation of rat dorsal root ganglion (DRG) neurons in vitro. The aim of this study was to identify factors involved in transferring the observed NMRT-induced effects to SCs and consequently to DRG neurons. Conditioned media of NMRT-treated (CM NMRT) and untreated SCs (CM CTRL) were tested by beta-nerve growth factor (ßNGF) ELISA and multiplex cytokine panels to profile secreted factors. The expression of nociceptive transient receptor potential vanilloid 1 (TRPV1) channels was assessed and the intracellular calcium response in DRG neurons to high-potassium solution, capsaicin or adenosine triphosphate was measured mimicking noxious stimuli. NMRT induced the secretion of ßNGF and pro-regenerative-signaling factors. Blocking antibody experiments confirmed ßNGF as the main factor responsible for neurotrophic/neuritogenic effects of CM NMRT. The TRPV1 expression or sensitivity to specific stimuli was not altered, whereas the viability of cultured DRG neurons was increased. Positive effects of CM NMRT supernatant on DRG neurons are primarily mediated by increased ßNGF levels.

2022

Quantum effects of magnetic
resonance reduce glycolysis

Thöni, D. Mauracher, A. Ramalingam, B. Fiechtner, A. M. Sandbichler & M. Egg, 2022: Quantum based effects of therapeutic nuclear magnetic resonance persistently reduce glycolysis, iScience, 12/2022

Abstract

Electromagnetic fields are known to induce the clock protein cryptochrome to modulate intracellular reactive oxygen species (ROS) via the quantum based radical pair mechanism (RPM) in mammalian cells. Recently, therapeutic Nuclear Magnetic Resonance (tNMR) was shown to alter protein levels of the circadian clock associated Hypoxia Inducible Factor-1a (HIF-1a) in a nonlinear dose response relationship. Using synchronized NIH3T3 cells, we show that tNMR under normoxia and hypoxia persistently modifies cellular metabolism. After normoxic tNMR treatment, glycolysis is reduced, as are lactate production, extracellular acidification rate, the ratio of ADP/ATP and cytosolic ROS, whereas mitochondrial and extracellular ROS, as well as cellular proliferation are increased. Remarkably, these effects are even more pronounced after hypoxic tNMR treatment, driving cellular metabolism to a reduced glycolysis while mitochondrial respiration is kept constant even during reoxygenation. Hence, we propose tNMR as a potential therapeutic tool in ischemia driven diseases like inflammation, infarct, stroke and cancer.

2022

Magnetic resonance accelerates
regeneration of ganglion neurons

Mann, B. Steinecker-Frohnwieser, A. Naghilou, F. Millesi, P. Supper, L. Semmler, S. Wolf, L. Marinova, L. Weigl, T. Weiss & C. Radtke, 2022: Nuclear Magnetic Resonance Treatment Accelerates the Regeneration of Dorsal Root Ganglion Neurons in vitro, Frontiers in Cellular Neuroscience, 03/2022, 16, 859545

Abstract

Functional recovery from peripheral nerve injuries depends on a multitude of factors. Schwann cells (SCs) are key players in the regenerative process as they develop repair-specific functions to promote axon regrowth. However, chronically denervated SCs lose their repair phenotype, which is considered as a main reason for regeneration failure. Previous studies reported a modulatory effect of low nuclear magnetic resonance therapy (NMRT) on cell proliferation and gene expression. To provide first insight into a possible effect of NMRT on cells involved in peripheral nerve regeneration, this study investigated whether NMRT is able to influence the cellular behavior of primary SC and dorsal root ganglion (DRG) neuron cultures in vitro. The effect of NMRT on rat SCs was evaluated by comparing the morphology, purity, proliferation rate, and expression levels of (repair) SC associated genes between NMRT treated and untreated SC cultures. In addition, the influence of (1) NMRT and (2) medium obtained from NMRT treated SC cultures on rat DRG neuron regeneration was examined by analyzing neurite outgrowth and the neuronal differentiation status. Our results showed that NMRT stimulated the proliferation of SCs without changing their morphology, purity, or expression of (repair) SC associated markers. Furthermore, NMRT promoted DRG neuron regeneration shown by an increased cell survival, enhanced neurite network formation, and progressed neuronal differentiation status. Furthermore, the medium of NMRT treated SC cultures was sufficient to support DRG neuron survival and neurite outgrowth. These findings demonstrate a beneficial impact of NMRT on DRG neuron survival and neurite formation, which is primarily mediated via SC stimulation. Our data suggest that NMRT could be suitable as a non-invasive auxiliary treatment option for peripheral nerve injuries and encourage future studies that investigate the effect of NMRT in a physiological context.

2021

Influencing central clock mechanisms and hypoxia

Thöni, R. Oliva, D. Mauracher & M. Egg, 2021: Therapeutic Nuclear Magnetic Resonance affects the core clock mechanism and associated Hypoxia-inducible factor-1, Chronobiology international, 38(8), 1120–1134

Abstract

The influence of low intensity electromagnetic fields on circadian clocks of cells and tissues has gained increasing scientific interest, either as a therapeutic tool or as a potential environmental hazard. Nuclear Magnetic Resonance (NMR) refers to the property of certain atomic nuclei to absorb the energy of radio waves under a corresponding magnetic field. NMR forms the basis for Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy and, in a low-intensity form, for NMR therapy (tNMR). Since the circadian clock is bi-directionally intertwined with hypoxic signaling in vertebrates and mammals, we hypothesized that low intensity electromagnetic fields, such as tNMR, might not only affect circadian clocks but also Hypoxia-Inducible Factor-1α (HIF-1α). As master regulator of the hypoxic signaling pathway, HIF-1α is known to dampen the circadian amplitude under reduced oxygen availability, while the hypoxic response of cells and organisms, itself, is tightly clock controlled. In a first experiment, we investigated if tNMR is able to act as Zeitgeber for the core clock mechanism of unsynchronized zebrafish and mouse fibroblast cells, using direct light irradiation and treatment with the glucocorticoid Dexamethasone as references. tNMR significantly affected the cell autonomous clocks of unsynchronized mouse fibroblast cells NIH3-T3, but did not act as a Zeitgeber. Similar to light irradiation and in contrast to treatment with Dexamethasone, tNMR did not synchronize expression profiles of murine clock genes. However, irradiation with tNMR as well as light significantly altered mRNA and protein expression levels of Cryptochrome1, Cryptochrome2 and Clock1 for more than 24 h. Changes in mRNA and protein after different treatment durations, namely 6 and 12 h, appeared to be nonlinear. A nonlinear dose-response relationship is known as hallmark of electromagnetic field induced effects on biological systems. The most prominent alterations were detected in murine HIF-1α protein, again in a nonlinear dose–response. In contrast to murine cells, zebrafish fibroblasts did not respond to tNMR at all. Light, a potent Zeitgeber for the peripheral clocks of fish, led to the expected synchronized clock gene oscillations of high amplitude, as did Dexamethasone. Hence, we conclude, mammalian peripheral clocks are more susceptible to tNMR than the direct light entrainable fish fibroblasts. Although light and tNMR did not act as Zeitgebers for the circadian clocks of unsynchronized murine cells, the significant observed effects might indicate downstream cell-physiological ramifications, which are worth future investigation. However, beside the effects tNMR exerts on the core clock mechanism of mammalian cells, the technology might be the first non-pharmacological approach to modify HIF-1α protein in cells and tissues. HIF-1α and the associated circadian clock play key roles in diseases with underlying ischemic background, such as infarct, stroke, and cancer and, also infectious diseases, such as Covid19. Hence, low intensity magnetic fields such as tNMR might be of significant medical interest.

2021

Magnetic resonance reduces inflammation in cells

Steinecker-Frohnwieser, B. Lohberger, N. Eck, A. Mann, C. Kratschmann, A. Leithner, W. Kullich & L. Weigl, 2021: Nuclear Magnetic Resonance Therapy Modulates the miRNA Profile in Human Primary OA Chondrocytes and Antagonizes Inflammation in Tc28/2a Cells, International Journal of Molecular Sciences, 05/2021, 22(11), 5959

Abstract

Nuclear magnetic resonance therapy (NMRT) is discussed as a participant in repair processes regarding cartilage and as an influence in pain signaling. To substantiate the application of NMRT, the underlying mechanisms at the cellular level were studied. In this study microRNA (miR) was extracted from human primary healthy and osteoarthritis (OA) chondrocytes after NMR treatment and was sequenced by the Ion PI Hi-Q™ Sequencing 200 system. In addition, T/C-28a2 chondrocytes grown under hypoxic conditions were studied for IL-1 induced changes in expression on RNA and protein level. HDAC activity an NAD(+)/NADH was measured by luminescence detection. In OA chondrocytes miR-106a, miR-27a, miR-34b, miR-365a and miR-424 were downregulated. This downregulation was reversed by NMRT. miR-365a-5p is known to directly target HDAC and NF-kB, and a decrease in HDAC activity by NMRT was detected. NAD+/NADH was reduced by NMR treatment in OA chondrocytes. Under hypoxic conditions NMRT changed the expression profile of HIF1, HIF2, IGF2, MMP3, MMP13, and RUNX1. We conclude that NMRT changes the miR profile and modulates the HDAC and the NAD(+)/NADH signaling in human chondrocytes. These findings underline once more that NMRT counteracts IL-1 induced changes by reducing catabolic effects, thereby decreasing inflammatory mechanisms under OA by changing NF-kB signaling.

2019

Comparison of the impact of light, magnetic
resonance and dexamethasone on cell clocks

Thöni, 2019: Impact of light radiation, nuclear magnetic resonance (NMR) and dexamethasone treatment on the transcriptional clock of the mouse fibroblast cell line NIH3T3, Master’s thesis, University of Innsbruck, Department of Zoology

Abstract

Nuclear magnetic resonance (NMR) is a physical phenomenon which is used for imaging (magnetic resonance imaging, MRI) and, at lower intensity, as a therapeutic tool (nuclear magnetic resonance therapy, tNMR) in regenerative medicine and for musculoskeletal disorders. However, virtually nothing is known about the biological effects of NMR. Only recently, the circadian clock of zebrafish cells and larvae was shown to be affected by the tNMR under constant darkness. In order to be able to translate these findings to humans, we now set out to investigate the impact of tNMR on a mammalian cell line, the mouse fibroblasts NIH3T3. For this purpose, we designed primers for quantitative Real time qPCR (qRT-PCR), in order to be able to quantify mRNA levels of major murine clock genes. Primer design was accomplished via the conserved regions of the core clock genes Cry1, Cry2, Clock1, Per1, and Per2, which were determined by comparing the respective mRNA sequences of zebrafish, mouse and human. We then cultured mouse (NIH3T3) and zebrafish (Z3) fibroblasts and exposed them either directly to light, tNMR or dexamethasone. The comparison between the different treatments was performed in order to be able to characterize the effects of tNMR also qualitatively. Our results demonstrate that the tNMR did not synchronize the transcriptional clock of mouse fibroblasts as dexamethasone did. However, tNMR significantly reduced the mRNA expression of the murine Cry1, Cry2, Clock1, and Per2 genes under constant dark conditions. The tNMR induced effects in mouse cells thereby resembled those of direct light exposure, which also led to reduced mRNA expression levels of specific clock genes. The transcriptional clock of zebrafish cells, in turn, was affected by dexamethasone and synchronized by light, as known from literature, but did not respond to the treatment with tNMR. Interestingly, the affected murine clock genes play a crucial role in bone formation and in the anti-inflammatory immune response. Hence, this study supports the potential of tNMR as therapeutic tool for chronic diseases linked to the circadian clock, although further research at the protein level has to be done.

2018

Influence on intracellular calcium and inflammatory processes

Steinecker-Frohnwieser, W. Kullich, A. Mann, H. G. Kress & L. Weigl, 2018: The therapeutic nuclear magnetic resonance changes the balance in intracellular calcium and reduces the interleukin-1β induced increase of NF-κB activity in chondrocytes, Clinical and Experimental Rheumatology 2018, 36, 294–301

Abstract

Objective: Osteoarthritis as the main chronic joint disease is characterised by the destruction of articular cartilage. Developing new, more effective and in particular non-invasive methods to achieve pain reduction of OA patients are of exceptional interest. Clinical observations demonstrated positive effects of therapeutically applied low nuclear magnetic resonance (NMRT) for the treatment of painful disorders of the musculoskeletal system. In this study the cellular mechanism of action of NMRT was examined on chondrocytes.

Methods: Cal-78 human chondrosarcoma cells were kept under inflammatory conditions by application of IL-1β. NMRT treated cells were tested for changes in histamine induced Ca2+ release by fura-2 calcium imaging. The effects of IL-1β and of NMRT treatment were further tested by determining intracellular ATP concentrations and the activity of MAP-kinases and NF-κB.

Results: NMRT influenced the intracellular calcium signalling by elevating the basal [Ca2+]. The peak calcium concentration evoked by 10 μM histamine was increased by IL-1β and this increase was reversed under NMRT treatment. Screening of different kinase-activities revealed an apparent increase in activity of MAPK/ERK and MAPK/JNK in NMRT stimulated cells, p38 was downregulated. The IL-1β-induced decline in intracellular ATP and the elevated NF-κB activity was reversed under NMRT stimulation.

Conclusion: Under inflammatory conditions, NMRT influenced cellular functions by modulating cellular calcium influx and/or calcium release. Further, NMRT induced changes in MAPK activities such as down-regulation of NF-κB and increasing intracellular ATP might help to stabilise chondrocytes and delay cartilage damage due to OA.

2018

Effects of magnetic resonance on cell clocks

Oliva, B. Jansen, F. Benscheidt, A. M. Sandbichler & M. Egg, 2018: Nuclear magnetic resonance affects the circadian clock and hypoxia-inducible factor isoforms in zebrafish, Biological Rhythm, Research, 2018, 5(5), 739–757

Abstract

Nuclear magnetic resonance (NMR) is used for magnetic resonance imaging and, at a lower intensity, as therapy for the treatment of musculoskeletal disorders. Due to the involvement of the circadian clock protein CRYPTOCHROME in the magnetic orientation of animals, it was repeatedly assumed that magnetic fields might affect the circadian rhythm of cells and organisms. Since circadian time keeping and hypoxic signaling are mutually intertwined, we investigated the effects of NMR on both cellular pathways in zebrafish fibroblast cells and larvae. In cells, basal mRNA expression of cryptochrome1aa was increased and oscillations of cryptochrome1aa and period1b were shifted in phase, while those of clock1a and period2 remained unaffected. Similarly, circadian oscillations of cryptochrome1aa and period1b were restored in zebrafish larvae, while those of clock1a and period2 remained unaltered. NMR also restored the circadian expression of the hypoxia-inducible factor (Hif) isoforms Hif-1α and Hif-3α at the mRNA and protein level, but had no effect on the expression of Hif-2α. Thus, NMR-mediated effects might differ substantially from the light-induced reset of the circadian clock in the same species and therefore represent an additional operation mode of the cellular clock, enabling distinct processing of photic and magnetic information.

2015

Effects of NMRT on liver regeneration

Budny, 2015: Effects of magnetic resonance therapy on the dynamics of liver regeneration, An experimental animal study, Inaugural dissertation, Medical Faculty of the Westfälische Wilhelms-Universität Münster, from the University Hospital Münster, Clinic for General and Visceral Surgery

Abstract

Nuclear magnetic resonance therapy, which can be repeated at will, has proven to be an innovative therapy for degenerative diseases such as osteoarthritis or osteoporosis. To investigate the effect of magnetic resonance therapy on liver regeneration after 70% liver resection and on untreated liver tissue, 108 male Lewis rats were randomized into six experimental groups. These included three control groups, in which only the abdomen was opened, and three resection groups – with a group size of n = 18 animals. In each group, either sham treatment or simultaneous application of magnetic resonance with one of two different programs (dose I or II) was performed on the first three postoperative days. Liver biopsies were taken on days 4, 7 and 14 after intravenous administration of 100 mg/ml bromodeoxyuridine (BrdU) per kg body weight. Weight and various serum parameters (AST, ALT, alkaline phosphatase) were examined as markers for possible liver damage. The progress of liver regeneration was assessed with mitoses, mitoses in the S phase, signs of inflammation, cell necrosis, connective tissue, glycogen and angiogenesis. Overall, no detrimental effect of the non-invasive procedure on healthy tissue was detected. Both programs had different effects on healthy and regenerating liver tissue. Regenerating tissue showed significantly faster proliferation under dose I than under dose II.

2014

Influence of NMRT on chondrocytes

Steinecker-Frohnwieser, L. Weigl, G. Weberhofer, W. Kullich & H. G. Kress, 2014: The Influence of Nuclear Magnetic Resonance Therapy (NMRT) and Interleukin IL1-b Stimulation on Cal 78 Chondrosarcoma Cells and C28/I2 Chondrocytes, Journal of Orthopedics and Rheumatology, 2014, 1(3), 1–9

Abstract

Introduction: For the last decade the Nuclear Magnetic Resonance (NMR) therapy has turned out a success in pain treatment of patients who suffer from osteoarthritis (OA) of knees or hands, low back pain and osteoporosis, respectively. While clinical outcome could be proved, less is known  about the underlying mechanism by which NMRT modulates cellular processes leading to observed pain reduction. This study implements the analysis of potential signal transduction pathways involved in NMRT signal transfer in Cal-78 chondrosarcoma cells and NMRT influencing cell growth and viability of interleukin IL-1β stimulated Cal-78 cells and C28/I2 chondrocytes. Changes in expression of inflammatory proteins like metalloproteinases MMP1, MMP3, MMP8, MMP9, MMP10 and MMP13, as well as interleukins IL6 and IL8 were evaluated.

Methods: Basic pathway analysis was performed by the gene array technology ensued by the reporter-gene technique (Cignal™ Reporter Assay). Cell proliferation was tested by calcein- and eFlour 670 staining; the S-phase of the cells was determined by use of the BrdU assay. Changes in expression of the inflammatory proteins were evaluated by performing quantitative RT-PCR, enzyme immuno assays and luminex measurements.

Results: The interpretation of the gene array combined with the results of the reporter gene assay roughly reveals indices of NMRT influencing the transforming growth factor (TGF)- β and Mitogen Activated Protein (MAP) kinase pathway. The cell growth and viability of both cell lines was not changed by NMRT although their inhibition caused by IL-1β was more pronounced in the absence of NMRT stimulation. Even though IL-1β provably stimulated the increase of the expression of MMPs and ILs, these effects seemed to be divergently regulated within the two cell lines. Interestingly at the level of RNA MMP13 and IL-8 are statistically down regulated by NMRT only in C28/ I2 cells.

Conclusion: Our findings concerning effects of IL-1β being less significant under NMRT than under control conditions, plus the reduced MMP-13 expression substantiate the postulated anti-inflammatory effect of NMRT relevant for pain relief. Clarification of how NMRT signaling is processed by targeted cells will broaden perspectives for clinical adaptations of NMRT by more precise and efficient application of this alternative therapeutically action.

2014

Effects of therapeutic magnetic
resonance on the circadian clock

Oliva, 2014: Effects of Therapeutic-NMR (MBST®-Nuclear Magnetic Resonance) on the Circadian Clock and the Hypoxic Signaling Pathway in Zebrafish Cells, Master thesis for the acquisition of the academic degree Master of Science (MSc) at the faculty of biology Leopold Franzens University of Innsbruck, Department of Ecophysiology

Abstract

Because of the lack of studies proving the effectivity of NMR on cell signaling pathways the aim of the following study was to investigate the effect of NMR (MBST®-ClosedSystem300) treatment on the circadian clock and the hypoxic signaling pathway at the molecular level.

For this purpose, a pilot experiment was performed to investigate the impact of treatment and sampling time on the resulting NMR (MBST®-ClosedSystem300) effect. The results of this first experiment confirmed our assumption that the daytime of the NMR (MBST®-ClosedSystem300) treatment might be crucial.

In summary, the NMR (MBST®-ClosedSystem300) treatment used in the present study caused significant alterations in the circadian oscillations of specific genes, indicating that the NMR (MBST®-ClosedSystem300) treatment might significantly affect two of the most important cell signaling circuitries for the maintenance of healthy chondrocytes, the circadian clock and the hypoxic signaling pathway.

2007

Influence on skin fibroblasts

Digel, E. Kurulgan, P. Linder, P. Kayser, D. Porst, G. J. Braem, K. Zerlin, G. M. Artmann & Temiz Artmann, 2007: Decrease in extracellular collagen crosslinking after NMR magnetic field application in skin fibroblasts, Medical and Biological Engineering and Computing, 45, 91–97

Abstract

Although biological effects of electromagnetic fields were investigated intensively, there is still no agreement on the significance of their effects. The underlying mechanisms and therapeutic importance are still mostly unknown too. In this study, primary cultures of human dermal fibroblasts were exposed to magnetic field at nuclear magnetic resonance (NMR) conditions for in total 5 days and 4 h/day. Among the investigated parameters were: cell proliferation rate, cell morphology, total protein concentration as well as content of skin-specific collagen types I, III, IV. NMR exposure induced distinct changes both in cellular and extracellular components. The extracellular matrix (ECM) of NMR-exposed cells had less cross-linked collagen. In particular, the increase of collagen of the soluble fraction was at 17.2 ± 2.9% for type I, 27.0 ± 1.86% for type III, 17.3 ± 1.46% for type IV (N = 6). In the absence of resonance frequency, the effects of magnetic field on ECM were less profound.

2005

Effects of magnetic resonance on cell proliferation

Temiz Artmann, P. Lindner, P. Kayser, I. Digel, G. M. Artmann & P. Lücker, 2005: NMR In Vitro Effects on Proliferation, Apoptosis, and Viability of Human Chondrocytes and Osteoblasts, Methods and Findings in Experimental and Clinical Pharmacology, 2005, 27(6), 391–394

Abstract

This study presents findings on the proliferation rate, cellular apoptosis, and viability of human chondrocyte and osteoblast cultures be/ore and after treatment with NMR pulse sequences. A commercially available nuclear magnetic resonance machine (MBSI®-Nuclear Magnetic Resonance Therapy) was used for treatment. The study was carried out/or 19 days, including 9 days of NMR exposure in a controlled, double-blind, randomized manner, using commercially available human cell lines. The study revealed that NMR treatment did not induce apoptosis or inhibit cell viability, but revealed a tendency of an elevated cell proliferation rate as observed by cell count.

Wir helfen Ihnen gerne weiter!

Jetzt Beratungstermin
vereinbaren

* Bitte füllen Sie alle mit einem Sternchen (*) markierten Felder aus

We are happy to help you!

Schedule a
consultation now ...

* Please fill in all fields marked with an asterisk (*).

This popup shows the full story from each testimonial when “Story lesen” is clicked. You don’t need to edit this text — it will be replaced automatically.

29May-Center-Test

Address

Indications

Contact us

Treatment Areas

Devices

    Schünemann group practice

    Address

    Alte Str. 18a
    90451
    Nürnberg
    Germany

    Indications

    Contact us

    +49 911 6427363
    praxis-schuenemann@t-online.de

    Treatment Areas

    Devices

      Private practice for orthopaedics and pain therapy – Alexander Graf

      Address

      Bahnhofstr. 27
      74858
      Aglasterhausen
      Germany

      Indications

      Contact us

      +49 6262 92 50 118
      info@privatpraxis-graf.de

      Treatment Areas

      Devices

        Fisiosport Alicante

        Address

        Calle del Sacerdote Isidro Albert, 20
        03010
        Alicante
        Spain

        Indications

        Contact us

        +34 656 740022
        info@fisiosportmurcia.es

        Treatment Areas

        Devices

          Clínica Lledó

          Address

          Calle Alloza nº 133 2ºD
          12001
          Castellón de la Plana
          Spain

          Indications

          Contact us

          +34 964240603
          contacto@clinicalledo.com

          Treatment Areas

          Devices

            Jam Physio

            Address

            452 Lytham Road
            FY4 1JQ
            Blackpool
            United Kingdom of Great Britain and Northern Ireland

            Indications

            Contact us

            +44 1253 343343

            Treatment Areas

            Devices

              Orthopaedic practice – Dr Stephan Mieter

              Address

              Robert-Koch-Str. 8
              06333
              Hettstedt
              Germany

              Indications

              Contact us

              +49 3476 851177
              info@orthopraxis-mieter.de

              Treatment Areas

              Devices

                VIDA srls – Juan Carlos Ghezzi

                Address

                Via Cremona 88
                26013
                Crema
                Italy

                Indications

                Contact us

                +39 374 650034
                jc@juancarlosghezzi.it

                Treatment Areas

                Devices

                  Orthopaedic Centre Rhine Neckar – Dr Hans-Christof Reitzner & Dr Martin Stock

                  Address

                  Katharinenstr. 36
                  75031
                  Eppingen
                  Germany

                  Indications

                  Contact us

                  +49 7262 912150
                  info@orthopaedie-eppingen.de

                  Treatment Areas

                  Devices

                    Practice – Dr med. Rainer Biglmaier

                    Address

                    Hauptstr. 32
                    14715
                    Nennhausen
                    Germany

                    Indications

                    Contact us

                    +49 176 64083830
                    rbiglmaier@web.de

                    Treatment Areas

                    Devices

                      Physio Advance Institute Burgos

                      Address

                      C/San Francisco Nº32
                      09005
                      Burgos
                      Spain

                      Indications

                      Contact us

                      +34 614 197640

                      Treatment Areas

                      Devices

                        Clínica Centrum – Antonio Castañeda

                        Address

                        C. Neptuno, 29
                        04700
                        El Ejido
                        Spain

                        Indications

                        Contact us

                        +34 950 487277
                        hola@antoniocastañeda.com

                        Treatment Areas

                        Devices

                          Practice Dr Karl-Friedrich Bröer

                          Address

                          Bessingerstr. 24
                          32547
                          Bad Oeynhausen
                          Germany

                          Indications

                          Contact us

                          +49 5731 307572

                          Treatment Areas

                          Devices

                            HIR – Hamburg Institute for Regenerative Medicine · Harry Finneisen

                            Address

                            Hohe Bleichen 18
                            20354
                            Hamburg
                            Germany

                            Indications

                            Contact us

                            +49 40 35714450
                            info@hir-praxis.de

                            Treatment Areas

                            Devices

                              MBST Physio and Joints Therapy Center FZ LLC.

                              Address

                              Building Ibn Sina 27 Block A, G05 A
                              Dubai
                              United Arab Emirates

                              Indications

                              Contact us

                              +971 4 2727006
                              info@mbstuae.com

                              Treatment Areas

                              Devices

                                Doc Medical Center

                                Address

                                27 Al Kinana Street
                                Doha
                                Qatar

                                Indications

                                Contact us

                                +974 44 753333
                                info@docmedc.com

                                Treatment Areas

                                Devices

                                  OrthoGO · Drs. med. Reza Pasha, Tim Broja & Jochen Urban

                                  Address

                                  Luisenstr. 98
                                  47799
                                  Krefeld
                                  Germany

                                  Indications

                                  Contact us

                                  +49 2151 9714890
                                  info@orthogo.de

                                  Treatment Areas

                                  Devices

                                    Clinica Fisiopat Valladolid

                                    Address

                                    Pio del Rio Ortega 16
                                    47014
                                    Valladolid
                                    Spain

                                    Indications

                                    Contact us

                                    +34 667 841874
                                    info@fisiopat.com

                                    Treatment Areas

                                    Devices

                                      Montebello Physiotherapy Studio

                                      Address

                                      Via San Gottardo 24
                                      6532
                                      Castione
                                      Switzerland

                                      Indications

                                      Contact us

                                      +41 91 8262121
                                      info@fisiomontebello.ch

                                      Treatment Areas

                                      Devices

                                        Clinica Bonaque

                                        Address

                                        La Vina, C. Guillermo Oliver, 4, Bajo
                                        30800
                                        Lorca
                                        Spain

                                        Indications

                                        Contact us

                                        +34 968 473877
                                        clinicabonaque@clinicabonaque.es

                                        Treatment Areas

                                        Devices